Vinicius Ernani, M.D.
Dr. Vinicius Ernani is a thoracic medical oncologist specializing in thoracic malignancies, including malignant pleural mesothelioma, lung cancer, and thymic cancers. He provides clinical care and develops and co-chairs clinical trials in lung cancer at the Mayo Clinic in Phoenix, Arizona. He is board-certified by the American Board of Internal Medicine in both Medical Oncology and Hematology.[1]
Education and Career
Dr. Ernani is originally from Lages-Santa Catarina Brazil, and he earned his medical degree at the Pontificia Universidade Catolica do Rio Grande do Sul, in Porto Alegre, Brazil. From there he completed an Internal Medicine residency at Jackson Memorial Hospital/University of Miami, then completed a Hematology/Oncology fellowship at the Winship Cancer Institute of Emory University in Atlanta, Georgia.
Dr. Ernani attributes his passion for treating lung cancer patients to the “superb role models and mentorship within the thoracic department” that he received during his fellowship at Emory University. After his fellowship, he served as an assistant professor at the Fred and Pamela Buffett Cancer Center of the University of Nebraska and was an active member of the National Comprehensive Cancer Network (NCCN) guidelines. Today he treats patients as a member of both the Oncology department and Hematology department at the Mayo Clinic in Phoenix, Arizona.[1]
Research
Dr. Ernani is actively involved in developing and co-chairing clinical trials for the treatment of lung cancer and malignant pleural mesothelioma. His research includes a Phase 2 randomized trial of adjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma and a pilot study of first-line Tumor Treating Fields for advanced or metastatic non-small cell lung cancer.[2]
Memberships
Dr. Ernani is a member of the Lung Cancer Disease Group Committee of Academic and Community Cancer Research United (ACCRU) and was previously a member of the Data Safety and Mentoring Committee (DSMC) at the University of Nebraska. He is also a member of the Career Development and Fellowship Committee of the International Association for the Study of Lung Cancer (IASLC) and of the American Society of Clinical Oncology (ASCO).[1]
